Repetitive Transcranial Magnetic Stimulation (rTMS) and Cognitive Behavioral Therapy (CBT) for Gambling Disorder
Launched by INDONESIA UNIVERSITY · Sep 14, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help people with gambling disorder, which is a serious addiction where individuals can't control their urge to gamble. The researchers want to see if combining two treatments—Repetitive Transcranial Magnetic Stimulation (rTMS), a non-invasive brain stimulation technique, and Cognitive Behavioral Therapy (CBT), a type of talk therapy—can effectively reduce cravings and improve treatment outcomes for people struggling with this disorder. Although CBT is currently the standard treatment, it can take a long time to see results, so this study aims to explore if adding rTMS can speed up recovery.
To participate in this trial, individuals must be between 18 and 70 years old and have a significant gambling problem, as determined by a specific scoring system. They also need to understand Bahasa Indonesia and be willing to receive treatment. However, people with certain conditions, such as severe mental health issues or neurological disorders, cannot join. The trial is not yet recruiting participants, but it promises to offer a hopeful new option for those affected by gambling disorder. If you or someone you know is interested, keep an eye out for updates on when recruitment will start!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects with pathological gambling (SOGS score ≥ 5)
- • Subjects aged 18-70 years old
- • Subjects who understand Bahasa Indonesia
- • Subjects who agree to participate and receive treatment
- Exclusion Criteria:
- • Subjects with history of psychotic disorder and personality disorder according to ICD-11
- • Subjects with severe neurological disorder comorbidities, which cause seizure or loss of consciousness
- • Subjects with intellectual disability
- • Subjects with history of neurostimulation
- • Subjects with history of medical implant
- • Subjects currently or expecting pregnancy
- • Subjects fulfilling diagnostic criteria of substance use disorder in the last 6 months
About Indonesia University
Indonesia University is a leading academic institution dedicated to advancing healthcare through rigorous clinical research. As a trial sponsor, the university leverages its extensive expertise in medical science and collaboration with top-tier researchers to design and implement innovative clinical trials. Committed to ethical standards and patient safety, Indonesia University aims to contribute to the global body of knowledge in medicine, enhance therapeutic options, and improve health outcomes for diverse populations. Through its comprehensive approach, the university fosters an environment of scientific inquiry and collaboration, driving progress in clinical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported